Cardiorenal syndromes: pathophysiology to prevention

Area of Science:

• Cardiology
• Nephrology
• Pathophysiology

Background:

• Heart and kidney dysfunction are strongly linked to patient morbidity and mortality.
• Understanding the complex interplay between cardiac and renal systems has been challenging due to a lack of clinical scenario categorization.
• Cardiorenal syndromes (CRSs) represent bidirectional injury between the heart and kidneys.

Purpose of the Study:

• To categorize cardiorenal syndromes (CRSs) into five distinct types based on clinical scenarios.
• To elucidate the common pathway of cell-to-cell death and apoptosis mediated by oxidative stress in CRSs.
• To review biomarkers, including catalytic iron, for assessing oxidative stress in CRSs.

Main Methods:

• Categorization of CRSs into five types based on the temporal relationship between cardiovascular disease and kidney disease.
• Description of the bidirectional injury mechanisms involving oxidative stress and apoptosis.
• Review of blood and urine biomarkers for assessing oxidative stress.

Main Results:

• Five types of cardiorenal syndromes (CRSs) are defined, illustrating specific clinical presentations of heart and kidney interactions.
• Types 1 and 2 involve cardiovascular disease leading to kidney injury, while Types 3 and 4 involve kidney disease impacting the heart.
• Type 5 CRS involves simultaneous systemic insult to both organs, such as sepsis.

Conclusions:

• The five-type categorization of CRSs provides a framework for understanding heart-kidney interactions.
• Oxidative stress and apoptosis are identified as key mechanisms in CRS pathophysiology.
• Biomarker assessment, including catalytic iron, is important for evaluating CRSs and oxidative stress.